KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Rad Laboratories (BIO) Invested Capital (2016 - 2026)

Bio-Rad Laboratories has reported Invested Capital over the past 18 years, most recently at $8.1 billion for Q1 2026.

  • Quarterly Invested Capital rose 2.33% to $8.1 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $8.1 billion through Mar 2026, up 2.33% year-over-year, with the annual reading at $8.7 billion for FY2025, 11.41% up from the prior year.
  • Invested Capital was $8.1 billion for Q1 2026 at Bio-Rad Laboratories, down from $8.7 billion in the prior quarter.
  • Over five years, Invested Capital peaked at $11.0 billion in Q1 2023 and troughed at $7.1 billion in Q2 2025.
  • The 5-year median for Invested Capital is $9.1 billion (2024), against an average of $9.0 billion.
  • Year-over-year, Invested Capital crashed 36.97% in 2022 and then rose 11.41% in 2025.
  • A 5-year view of Invested Capital shows it stood at $10.8 billion in 2022, then dropped by 8.07% to $9.9 billion in 2023, then dropped by 21.76% to $7.8 billion in 2024, then rose by 11.41% to $8.7 billion in 2025, then fell by 6.95% to $8.1 billion in 2026.
  • Per Business Quant, the three most recent readings for BIO's Invested Capital are $8.1 billion (Q1 2026), $8.7 billion (Q4 2025), and $7.9 billion (Q3 2025).